SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-030128
Filing Date
2014-05-14
Accepted
2014-05-14 07:32:19
Documents
6
Period of Report
2014-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v378412_8k.htm 8-K 28650
2 EXHIBIT 3.1 v378412_ex3-1.htm EX-3.1 58571
3 EXHIBIT 17.1 v378412_ex17-1.htm EX-17.1 757
4 EXHIBIT 99.1 v378412_ex99-1.htm EX-99.1 9501
5 GRAPHIC tex17-1pg01.jpg GRAPHIC 36151
6 GRAPHIC image_001.jpg GRAPHIC 138409
  Complete submission text file 0001144204-14-030128.txt   339635
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 14839207
SIC: 2834 Pharmaceutical Preparations